Navarro Mariel, Negre Sergio, Matoses María Luisa, Golombek Sergio G, Vento Maximo
Division of Neonatology, University Hospital La Fe, Valencia, Spain.
Acta Paediatr. 2009 Jul;98(7):1214-7. doi: 10.1111/j.1651-2227.2009.01279.x. Epub 2009 Apr 16.
To describe a series of patients who received intravenous immunoglobulin (IVIg) for the treatment of neonatal hyperbilirubinaemia and developed necrotizing enterocolitis (NEC) shortly thereafter.
We describe three healthy breastfed newly born infants with isoimmunization-derived hyperbilirubinaemia refractory to phototherapy who were treated with IVIg. Shortly after the perfusion finished they developed clinical and radiological signs compatible with NEC and needed antibiotic therapy, prolonged parenteral nutrition and even surgery in one case. Other conditions such as septicaemia or coagulopathy were ruled out. Microscopic examination of the resected intestine revealed the presence of disseminated thrombi obstructing multiple minor vessels of the mesenteric circulation.
IVIg in the newborn period should be cautiously employed and always administered under strict medical control.
描述一系列接受静脉注射免疫球蛋白(IVIg)治疗新生儿高胆红素血症并在此后不久发生坏死性小肠结肠炎(NEC)的患者。
我们描述了三名健康的母乳喂养新生儿,他们患有光疗难治的同种免疫性高胆红素血症,接受了IVIg治疗。灌注结束后不久,他们出现了与NEC相符的临床和放射学体征,需要抗生素治疗、长期肠外营养,其中一例甚至需要手术。排除了败血症或凝血病等其他情况。对切除的肠道进行显微镜检查发现存在弥散性血栓,阻塞了肠系膜循环的多个小血管。
新生儿期应谨慎使用IVIg,且必须在严格的医疗控制下给药。